These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26516352)

  • 1. Metabolic syndrome and benign prostatic hyperplasia: association or coincidence?
    Rył A; Rotter I; Miazgowski T; Słojewski M; Dołęgowska B; Lubkowska A; Laszczyńska M
    Diabetol Metab Syndr; 2015; 7():94. PubMed ID: 26516352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between selected hormone and protein levels in serum and prostate tissue homogenates in men with benign prostatic hyperplasia and metabolic disorders.
    Grzesiak K; Rył A; Baranowska-Bosiacka I; Rotter I; Dołęgowska B; Słojewski M; Sipak-Szmigiel O; Ratajczak W; Lubkowska A; Metryka E; Piasecka M; Laszczyńska M
    Clin Interv Aging; 2018; 13():1375-1382. PubMed ID: 30122909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone concentration, metabolic disorders and immunoexpression of androgen and estrogen-alpha receptors in men with benign prostatic hyperplasia and testosterone deficiency syndrome.
    Ryl A; Rotter I; Slojewski M; Dolegowska B; Grabowska M; Baranowska-Bosiacka I; Laszczynska M
    Folia Histochem Cytobiol; 2015; 53(3):227-35. PubMed ID: 26400665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Analysis of the SRD5A1 and SRD5A2 Genes in Patients with Benign Prostatic Hyperplasia with Regard to Metabolic Parameters and Selected Hormone Levels.
    Rył A; Rotter I; Grzywacz A; Małecka I; Skonieczna-Żydecka K; Grzesiak K; Słojewski M; Szylińska A; Sipak-Szmigiel O; Piasecka M; Walczakiewicz K; Laszczyńska M
    Int J Environ Res Public Health; 2017 Oct; 14(11):. PubMed ID: 29084161
    [No Abstract]   [Full Text] [Related]  

  • 5. Lipid Accumulation Product (LAP) as an Index of Metabolic and Hormonal Disorders in Aging Men.
    Rotter I; Rył A; Szylińska A; Pawlukowska W; Lubkowska A; Laszczyńska M
    Exp Clin Endocrinol Diabetes; 2017 Mar; 125(3):176-182. PubMed ID: 27898988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The underlying mechanism of metabolic syndrome on benign prostatic hyperplasia and prostate volume.
    Xia BW; Zhao SC; Chen ZP; Chen C; Liu TS; Yang F; Yan Y
    Prostate; 2020 May; 80(6):481-490. PubMed ID: 32104919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of metabolic syndrome on benign prostatic hyperplasia in elderly Chinese men.
    Zhang X; Zeng X; Liu Y; Dong L; Zhao X; Qu X
    Urol Int; 2014; 93(2):214-9. PubMed ID: 24862628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Relationship between Eicosanoid Levels and Serum Levels of Metabolic and Hormonal Parameters Depending on the Presence of Metabolic Syndrome in Patients with Benign Prostatic Hyperplasia.
    Grzesiak K; Rył A; Stachowska E; Słojewski M; Rotter I; Ratajczak W; Sipak O; Piasecka M; Dołęgowska B; Laszczyńska M
    Int J Environ Res Public Health; 2019 Mar; 16(6):. PubMed ID: 30897712
    [No Abstract]   [Full Text] [Related]  

  • 9. Association of hormonal dysregulation with metabolic syndrome in older women: data from the InCHIANTI study.
    Maggio M; Lauretani F; Ceda GP; Bandinelli S; Basaria S; Paolisso G; Ble A; Egan JM; Metter EJ; Abbatecola AM; Zuliani G; Ruggiero C; Valenti G; Guralnik JM; Ferrucci L
    Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E353-8. PubMed ID: 16968811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men.
    Gannagé-Yared MH; Khalife S; Semaan M; Fares F; Jambart S; Halaby G
    Eur J Endocrinol; 2006 Jul; 155(1):167-76. PubMed ID: 16793964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia.
    Hammarsten J; Högstedt B
    Blood Press; 1999; 8(1):29-36. PubMed ID: 10412880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of metabolic profile and abdominal fat distribution between karyotypically normal women with premature ovarian insufficiency and age matched controls.
    Ates S; Yesil G; Sevket O; Molla T; Yildiz S
    Maturitas; 2014 Nov; 79(3):306-10. PubMed ID: 25085705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower levels sex hormone-binding globulin independently associated with metabolic syndrome in pre-elderly and elderly men in China.
    Pang XN; Hu Y; Yuan Y; Shen JP; Zha XY; Sun X
    J Geriatr Cardiol; 2013 Mar; 10(1):28-33. PubMed ID: 23610571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impacts of metabolic syndrome and lifestyle on the prevalence of benign prostatic hyperplasia requiring treatment: historical cohort study of 130 454 men.
    Yoo S; Oh S; Park J; Cho SY; Cho MC; Jeong H; Son H
    BJU Int; 2019 Jan; 123(1):140-148. PubMed ID: 30125452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoproteins, sex hormones and inflammatory markers in association with prostate cancer.
    Grosman H; Fabre B; Mesch V; Lopez MA; Schreier L; Mazza O; Berg G
    Aging Male; 2010 Jun; 13(2):87-92. PubMed ID: 19921964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-sectional association between testosterone, sex hormone-binding globulin and metabolic syndrome: The Healthy Twin Study.
    Moon H; Choi I; Kim S; Ko H; Shin J; Lee K; Sung J; Song YM
    Clin Endocrinol (Oxf); 2017 Nov; 87(5):523-531. PubMed ID: 28581026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low 25-OH vitamin D is associated with benign prostatic hyperplasia.
    Haghsheno MA; Mellström D; Behre CJ; Damber JE; Johansson H; Karlsson M; Lorentzon M; Peeker R; Barret-Connor E; Waern E; Sundh V; Ohlsson C; Hammarsten J
    J Urol; 2013 Aug; 190(2):608-14. PubMed ID: 23399651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of sex hormones to lipids and lipoproteins in nondiabetic men.
    Haffner SM; Mykkänen L; Valdez RA; Katz MS
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1610-5. PubMed ID: 8263149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of metabolic syndrome on the relationship between fatty acids and the selected parameters in men with benign prostatic hyperplasia.
    Grzesiak K; Rył A; Ratajczak W; Stachowska E; Rotter I; Słojewski M; Sipak O; Walczakiewicz K; Laszczyńska M
    Aging (Albany NY); 2019 Mar; 11(5):1524-1536. PubMed ID: 30867336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous sex hormones and metabolic syndrome in aging men.
    Muller M; Grobbee DE; den Tonkelaar I; Lamberts SW; van der Schouw YT
    J Clin Endocrinol Metab; 2005 May; 90(5):2618-23. PubMed ID: 15687322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.